Five Prime Therapeutics Inc (FPRX) Return on Investment ROI from the fourth quarter of 2020 to fourth quarter of 2019 and for the year 2020, average high and low, overall ranking from Dec 31 2020 to Dec 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Five Prime Therapeutics Inc   (NASDAQ: FPRX)


Five Prime Therapeutics Inc's ROI from its fourth quarter of 2020 to the fourth quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Five Prime Therapeutics Inc's ROI in the fourth quarter of 2020?
Five Prime Therapeutics Inc recorded a cumulative net loss of $-84 million during 12 months ending in the fourth quarter of 2020, resulting in a negative return on investment (ROI) of -42.38%.

Within the Healthcare sector 481 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2020 from 0 to 3866.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Investment Change TTM -18.97 % -36.05 % -33.43 % -31.65 % -28.98 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 309 137 165 184 201
Return On Investment (TTM) -42.38 % -55.17 % -53.56 % -55.78 % -55.87 %
FPRX's Overall Ranking # 3866 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 15.76 % -11.88 % -10.76 % -10.99 % -8.64 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -84 -95 -104 -122 -137

FPRX Company Profile >> Back to FPRX Roi Comparisons >> See Annual FPRX Return On Investment



Return On Investment FPRX's Ranking
Within: No.
Industry # 207
Sector # 482
Overall # 3866

Return On Investment Statistics
High Average Low
95.94 %
-21.34 %
-55.87 %
(Dec 31 2015)   (Dec 31 2019)







Financial Statements
Five Prime Therapeutics Inc's IV. Quarter Investments $ 309 Millions FPRX's Balance sheet
Five Prime Therapeutics Inc's IV. Quarter Income $ -21 Millions Quarterly FPRX's Income Statement
FPRX's Income by Division See FPRX's Income by Division


FPRX Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016
Total Investments in Millions 309 201 294 293 410
Y / Y Investment Growth 53.87 % -31.6 % 0.33 % -28.44 % -12.05 %
Net Income in Millions -84 -137 -140 -150 -66
Y / Y Net Income Growth - - - - -
Annual Return On Investment -27.25 % -68.22 % -47.76 % -51.26 % -16.04 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FPRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FPRX's Competitors
Subscribers only: Roi for Five Prime Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for FPRX's Customers

Other Ratios
FPRX's Roa FPRX's Inventory Turnover Ratio FPRX's Growth Rates FPRX's Dividend Statistics
FPRX's Profitability Ratios FPRX's Asset Turnover Ratio FPRX's Dividend Growth
FPRX's Roe FPRX's Valuation Ratios FPRX's Financial Strength Ratios FPRX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2020, within Healthcare Sector ROI

Date modified: 2026-06-22T14:32:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.